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Background: Atherosclerosis has been widely accepted as an inflammatory disease of vascular, adhesion molecules
play an important role in the early progression of it. The aim of the present study was to evaluate the effect of
kaempferol on the inflammatory molecules such as E-selectin (E-sel), intercellular adhesion molecule-1 (ICAM-1),
vascular cell adhesionmolecule-1 (VCAM-1) and monocyte chemotactic protein-1 (MCP-1) in high cholesterol
induced atherosclerosis rabbit models.
Methods: Thirty male New Zealand white (NZW) rabbits were randomly divided into five groups, control group,
model group, fenofibrate (12mg/kg) group and kaempferol groups (150 mg/kg and 30 mg/kg). The rabbits were fed
with a normal diet or a high cholesterol diet for 10 weeks. Levels of blood lipids, serum tumour-necrosis factor-alpha
(TNF-α) and serum interleukin-1beta (IL-1β) were detected at the end of the sixth and tenth week. Malonaldehyde
(MDA) level and superoxide dismutase (SOD) activity in serum were also determined. Lesion areas of the aorta were
measured with morphometry analysis after ten weeks. Gene expression of E-sel, ICAM-1, VCAM-1 and MCP-1 in aortas
was determined by RT-PCR (reverse transcription-polymerase chain reaction). Immunohistochemical staining was
employed to measure protein expression of E-sel, ICAM-1, VCAM-1 and MCP-1.
Results: Model rabbits fed with ten weeks of high-cholesterol diet developed significant progression of atherosclerosis.
Compared with the control, levels of blood lipids, TNF-α, IL-1β and MDA increased markedly in serum of model rabbits,
while SOD levels decreased. Gene and protein expressions of E-sel, ICAM-1, VCAM-1 and MCP-1 in atherosclerotic
aortas increased remarkably in model group. However, comparing to the model rabbits, levels of TNF-α, IL-1β and MDA
decreased significantly and serum SOD activity increased, gene and protein expressions of E-sel, ICAM-1, VCAM-1 and
MCP-1 in aortas decreased significantly with the treatment of kaempferol.
Conclusion: Kaempferol shows anti-atherosclerotic effect by modulating the gene and protein expression of
inflammatory molecules.
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Cardiovascular disease (CVD) continues to be the leading
cause of death in developed countries nowadays. As the
most important contributor of CVD, atherosclerosis is
arousing great attention worldwide. With the develop-
ment and progression of atherosclerosis, a great deal of
lipid deposits and fibrous plaques accumulate in arteries
of some critical organs, especially heart and brain, leading* Correspondence: zhouyuanda001@163.com
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reproduction in any medium, provided the orto the formation of thrombus, which is responsible for
most of the breakouts of clinical vascular events [1].
Atherosclerosis is currently well accepted as a chronic
inflammation of arteries. The lesions of atherosclerosis
represent a protective and inflammatory response against
different and multiple risk agents including cholesterol, el-
evated oxidated LDL, free radicals caused by cigarette
smoking, hypertension, diabetes and infections [2]. A re-
cent report found some new risk factors in the pathogen-
esis of atherosclerosis such as homocysteinemia, elevated
plasma levels of lipoprotein (a) [Lp(a)], fibrinogen,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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hypercoagulability [3].
Inflammatory mechanisms play a critical role in the
pathogenesis of atherosclerosis. In the early phase of
atherosclerosis, dysfunction of endothelium leads to the
increased permeability of endothelium and adhesiveness
of leukocytes to artic wall. The production of procoagu-
lant agents including vasoactive molecules, cytokines
and growth factors can also be induced in endothelium.
Blood monocytes adhere to epithelium, migrate into in-
tima and become intimal macrophages, then change to
foam cells by excessive ingestion of modified lipoprotein
and gradually form the so called fatty streak [2].
The initial stage of inflammation of atherosclerosis is
usually silent and long with increased adhesion of mono-
cytes in arterial endothelium [4]. Adhesion molecules
and monocyte chemotactic protein-1 (MCP-1) partici-
pate in the progress and play an important role. Fisrtly,
selectin including E-selectin (E-sel), P-selectin(P-sel),
and L-selectin (L-sel) facilitate the rolling of molecules
on the surface of endothelium cells, then adhesion mole-
cules, such as vascular adhesion molecule-1 (VCAM-1)
and intercellular adhesion molecule-1 (ICAM-1) mediate
the advanced and firm adhesion of monocytes. Lastly,
with the function of MCP-1, monocytes pass though
endothelium and migrate into intima [5,6]. Damaged
endothelial cells, arterial lesions from atherosclerosis ex-
periment model and human all show increased expression
of these molecules including E-sel, ICAM-1, VCAM-1
and MCP-1 [7,8]. Therefore, one possible mechanism for
ameliorating atherosclerosis is the down-regulation of
pro-atherogenic molecules such as E-sel, ICAM-1,
VCAM-1 and MCP-1.Besides, in the inflammatory pro-
gress of atherosclerosis, activation of endothelial cells and
mactophages leads to the release of various kinds of cyto-
kines, chemokines, and growth factors, which in return
regulate the continued and advanced accumulation and
migration of leukocytes, thus induce further inflammation
[2]. Pro-inflammatory cytokines such as tumour necrosis
factor-alpha (TNF-α) and interleukin-1beta (IL-1β) par-
ticipate in it by inducing E-sel, ICAM-1 and VCAM-1 ex-
pression in endothelial cells [9], releasing of other
inflammatory mediators and inducing apoptosis of endo-
thelial cells. Previous studies revealed that elevated levels
of TNF-α and IL-1β in patients with CVD have been
detected [10,11], indicating that TNF-α and IL-1β are two
important cytokines in vascular inflammation and highly
associated with atherosclerosis. Recent studies also sug-
gested that, inflammatory biomarkers such as TNF-α, IL-
1β, E-sel, ICAM-1, VCAM-1 and MCP-1 may play a po-
tential role for the prediction of risk for developing CVD
and may correlate with the severity of CVD [12,13].
Kaempferol(3,5,7-trihydroxy-2-(4-hydroxyphenyl)-4H-
1-benzopyran-4-one), a yellow compound with a lowmolecular weight (MW: 286.2 g/mol), is a common nat-
ural flavonoid. This flavonoid is abundant in many plant-
derived foods and traditional medicine. It has been reported
that kaempferol and its glycosides have many kinds of
pharmacological activities, such as antioxidant, anti-
inflammatory, anticancer, antimicrobial, neuroprotective,
antidiabetic, analgesic and anti-allergic activities [14]. And
results of some studies suggested that the dietary intake of
kaempferol-rich foods can reduce risk of developing several
disorders including cardiovascular diseases [15,16].
Therefore we considered kaempferol to be a potent
and effective agent against atherosclerosis. So far, the re-
searches about the antioxidant, anti-inflammatory and
cardioprotective effect of kaempferol have been mostly
centered on endothelium cells in vitro. However, in vivo
studies related to the anti-atherosclerosis effect of
kaempferol are so rare. So the aim of the present study
was to investigate the protective effect of kaempferol on
atherosclerosis rabbit models. And our study will be fo-
cused on the anti-inflammation effect and its influence
on the expression of inflammatory molecules E-sel,
ICAM-1, VCAM-1 and MCP-1 in the aorta of rabbits.
Besides, Fenofibrate was designed as a positive control
in our study.
As a commonly used and successful atherosclerosis
animal model, New Zealand White rabbits were chosen
in our experiment. The lipoprotein metabolism and car-
diovascular system of rabbits are much similar to those
of humans, and they have been proved as the excellent
model for human atherosclerosis [17,18].
Materials and methods
Animals and experimental procedures
This study was approved by the Animal Ethics Commit-
tee, Chongqing Medical University. Thirty male New
Zealand White rabbits with average body weight be-
tween 2.0± 0.5 kg were purchased from Experimental
Animal Center, Chongqing Medical University (Grade II,
Certificated SCXKYu 2012–0001). High-cholesterol diet
(normal diet supplemented with 1% cholesterol, 10%
yolk powder, 5% animal oil) was supplied by Experimen-
tal Animal Center, Chongqing Medical University. The
animals were housed separately in cages under standard
animal house conditions with a 12 h light /dark cycle at
the temperature of 25°C. All animals had free access to
water.
The rabbits were all fed on a normal diet for one week
for adaptation, subsequently were divided randomly into
five groups of six animals in each: control group (Control)
was fed a normal diet, model group (Model) was fed with
high cholesterol diet, fenofibrate group (Fenofibrate,
positive control group) was fed with high-cholesterol
diet plus fenofibrate (Laboratoires Fournier S.A., Dijon,
France; 12 mg/kg/day), kaemlferol group of high dosage
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(Kaempferol-L) were fed with similar high-cholesterol diet
plus different doses of Kaempferol (ZeLang Medicine
Science and Technology Co., Ltd., Nanjing, China),150
and 30 mg/kg/day respectively. All the groups were fed
with a diet of 120 g/day for ten weeks. The main ex-
perimental procedures were described in a flow chart
as shown in Figure 1.
At the end of the tenth week, all animals were fasted
overnight and sacrificed by intravenous injection of
pentobarbital (Laboratories, Urchem Ltd., Shanghai,
China, 60 mg/kg body weight).Immediately after opening
the chest, the aorta was excised, then dissected longitu-
dinally and separated into three portions. The first por-
tion, a one-centimeter segment between the first and the
second intercostals artery was fixed in 10% neutral buff-
ered formalin for 1 day and paraffin-embedded; and it
was used for histological and immunohistochemical ana-
lysis. The second portion, a segment between the second
and the third intercostals artery, was snap-frozen in li-
quid nitrogen and stored at −70°C until being used for
PCR. The third portion, a segment between the third
and the seventh intercostals artery was stained with oil
red O (sigma, USA) for 30 minutes, then transferred to
70% alcohol for differentiation. 15 min later, it was
washed and taken photo with a digital camera (Olympas,
Janpan). The percentage of oil red O-positive area to the
internal surface was measured with a computer-assisted
morphometry system (Image Pro Plus 6.0, USA).
Weight and serum lipids determination
At the end of the sixth and tenth week, all the rabbits were
weighted and 2.0 mL blood was taken via the marginal ear
vein from each rabbit and centrifuged at 8,000 g for 10 min.
Obtained serum was analyzed in an automatic blood chem-
ical analyzer (Beckman Instruments, USA) and the serum
concentrations of total cholesterol (TC), triglyceride (TG),
high density lipoprotein cholesterol (HDL-C) and low dens-
ity lipoprotein cholesterol (LDL-C) were determined.Figure 1 Flow chart describing the experimental design. ELISA: Enzyme
chain reaction; IHC: Immuohistochemistry.Evaluation of serum TNF-α and IL-1β
At the end of tenth week, TNF-α and IL-1β concentrations
in the collected serum were detected with commercially
available kits (Rapidbio Lab Co., California, USA) under the
manufacturer’s instructions by the method of Enzyme-
linked immunosorbent assay (ELISA). Values of samples
were calculated from a standard curve generated from stan-
dards of known concentrations. Absorbance at 450 nm was
detected using microplate reader (Bio-Rad, USA).
Evaluation of serum SOD and MDA
After six and ten weeks, SOD and MDA levels in the
collected serum of rabbits were detected by colorimetric
method of xanthine oxidase and thiobarbituric acid with
kits (Nanjingjiancheng Bioengineering Institute, Nanjing,
China) respectively. The absorbance was measured with
UV–vis spectrophotometer (Shimadzu,Japan) at the wave-
length of 550 nm and 532 nm respectively, according to
the instructions of the kits.
Histological and immunohistochemical analysis
The first aorta portion, the paraffin-embedded segment
between the first and the second intercostals artery, was
cut into five non-consecutive serials of 5-μm-thick sec-
tions. The first serial was stained with hematoxylin and
eosin for observation under light microscopy (Olympas,
Japan). The other four serials of sections were incubated
with primary antibodies to E-sel (Bioss, Beijing, China;
1:100 dilution), ICAM-1 (Bioss, Beijing, China; 1:100 dilu-
tion), VCAM-1 (Abcam Inc., Cambridge, USA; 1:100 dilu-
tion) or MCP-1 (Bioss, Beijing, China;1:100 dilution)
respectively. After washing, specific biotinylated secondary
antibodies (biotinylated goat anti-mouse IgG for VCAM-
1, and biotinylated goat anti-rabbit IgG for E-sel, ICAM-1
and MCP-1) were applied, followed by avidin-biotin
peroxidase complexes (Histostain™-Plus Kits, Beijing
Zhongshan Goldenbridge Company, China). Antibody
binding was visualized with 3, 3-diaminobenzidin (DAB).
Sections were counterstained with hematoxylin. After-linked immunosorbent assay; RT-PCR: reverse transcription-polymerase
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and staining intensity of each section were measured with
use of a computerized image analysis program (Image-Pro
Plus 6.0, USA).
For the immunohistochemical semiquantitative assess-
ment of E-sel, ICAM-1, VCAM-1 and MCP-1expression,
immunohistochemical score (HIS, ranging from 0–12)
was applied. It is calculated by multiplication of the per-
centage of immunoreactive cells (quantity score) with
the staining intensity (staining intensity score). Quantity
score was calculated based on the following scoring sys-
tem: no staining is scored as 0, 1–10% of cells stained
scored as 1, 11–50% as 2, 51–80% as 3, and 81–100% as 4.
Staining intensity is rated on a scale of 0 to 3, with
0 = negative; 1 = weak; 2 = moderate, and 3 = strong.
Determination of E-sel, ICAM-1, VCAM-1 and MCP-1 gene
expression
Total RNA was isolated from the second portion of
aorta using TRIZOL (DingGuo Biotechnology Co. Ltd,
Beijing, China). To avoid the interference of DNA, 4 μL
of the obtained RNA was dealt with DNase (Promega,
Madison, USA) in 10 μL reaction mixture before reverse
transcription. Subsequently, 4 μL of the DNA-free RNA
were reverse transcribed into cDNA in 20 μL reaction
mixture using a reverse transcriptase (Toyobo, Osaka,
Japan). Reverse transcription was carried out for 10 min
at 30°C, 60 min at 42°C, followed by an inactivation step
at 99°C for 5 min. Target gene expressions were deter-
mined by semi-quantitative PCR with β-actin as an in-
ternal standard. PCR amplification was performed on an
Gene Cycler (Bio-Rad, USA) in a total volume of 25 μL,
which was composed of 1.0 μL of cDNA template, 10 ×
PCR buffer (50 mM KCl, 10 mM Tris–HCl, 2.5
mMMgCl2, pH 8.3), 0.2 mM dNTPs (Genview scientific
Inc., USA), 20 pmol/μL forward primers, 20 pmol/μL re-
verse primers,1.0 U of Taq DNA polymerase (TaKaRa
Co. Ltd., Tokyo, Japan). The amplification procedure
consisted of an initial denaturation step for 2 min atTable 1 Primers sequence of target genes
Target genes Gene bank accession no. Primers
β-Actin NM_001101683.1 5′ -TTCCAGCCCTCC
5′ -GCCCGACTCGTC
E-sel NM_001082312.1 5′ - AATGGCAGATA
5′ -TGGCTTGGAAGA
ICAM-1 AB128157.1 5′ -GACATTCTTGAA
5′ -CGGACACAGCTC
VCAM-1 NM_001082152.1 5′ -GGAGACACTGTC
5′ -TCCTTTCATGTTG
MCP-1 M28883.1 5′ -GGTGTAAAGGCA
5′ -AGGATAGGAAAG94°C, 35 cycles of denaturation at 94°C for 30 sec,
annealing at the temperature indicated in Table 1 for 1
min, and extension at 72°C for 30 sec, followed by a final
extension step for 10 min at 72°C. Electrophoresis was
carried out at 5 V/cm for 30 min on a 2% agarose gel and
PCR products were visualized with silver staining. Absor-
bances of each band were determined by densitometric
analysis using the one-Dscan gel analysis software
(Scanalytics, Billerica, USA). mRNA levels were expressed
as the ratios between target genes and β-actin.
Statistical analysis
Results were expressed as mean±SD. Statistic analysis was
carried out using the SPSS statistical package version 10.0
(SPSS Inc., USA). Student’s t-test was performed to com-
pare means between two groups. The p value<0.05 or 0.01
was considered to be statistically significant.
Results
Body weight and serum lipids analysis
Bodyweight and serum lipids were measured after six
and ten weeks respectively, and the obtained data were
shown in Table 2. According to Table 2, there was no
significant difference in bodyweight among any of the
groups at t = 6 week and at t = 10 week (p > 0.05). After
feeding on high cholesterol diet for 6 and 10 weeks,
serum lipid levels including total cholesterol (TC), tri-
glyceride (TG), high density lipoprotein cholesterol
(HDL-C) and low density lipoprotein cholesterol
(LDL-C) of model rabbits all increased greatly (P<0.01)
compared with control rabbits. Treatment of fenofibrate
(12 mg/kg) or kaempferol (30 mg/kg and 150 mg/kg) for
six and ten weeks significantly lowered TC, TG, HDL-C
and LDL-C levels of rabbits in comparison to the model
group (p < 0.01 or P<0.05).
Serum inflammatory factors analysis
As has mentioned in Background, TNF-α and IL-1β are
two important inflammatory factors in the progressionAnnealing temperature (°C) Size (bp)
TTCCT- 3′ 56 315
ATACT- 3′
CAGAGAACT- 3′ 49 219
GAATAACT- 3′
CAGTGACAG- 3′ 46 183
TCAGTA- 3′
ATTATCTCCTG- 3′ 58 336
GCTTTTCTTGC- 3′
GGTGTG- 3′ 52 214
GATGGG- 3′
Table 2 Changes of body weight and serum lipid levels after six and ten weeks in different groups (mean± SD, n=6)
Control Model Fenofibrate Kaempferol-H Kaempferol-L
Bodyweight (kg)
Week 6 2.49 ± 0.22 2.82 ± 0.36 2.65 ± 0.24 2.68 ± 0.28 2.66 ± 0.25
Week 10 2.93 ± 0.15 3.24 ± 0.40 3.15 ± 0.33 3.10 ± 0.13 3.09 ± 0.24
TC (mmol/L)
Week 6 1.13 ± 0.33 6.01 ± 2.48## 2.43 ± 0.57** 1.52 ± 0.24** 2.74 ± 0.83**
Week 10 1.11 ± 0.24 9.36 ± 3.96## 4.26 ± 1.44** 2.97 ± 1.41** 3.70 ± 1.14**
TG (mmol/L)
Week 6 0.58 ± 0.16 1.80 ± 0.47## 1.09 ± 0.32** 0.85 ± 0.10** 0.88 ± 0.27**
Week 10 0.62 ± 0.1 2.26 ± 0.82## 0.88 ± 0.14** 1.39 ± 0.63* 1.30 ± 0.42*
HDL-C (mmol/L)
Week 6 0.65 ± 0.09 1.92 ± 0.57## 1.04 ± 0.24** 0.83 ± 0.16** 1.04 ± 0.21**
Week 10 0.68 ± 0.14 2.51 ± 0.74## 1.76 ± 0.67* 1.29 ± 0.57** 1.64 ± 0.37*
LDL-C (mmol/L)
Week 6 0.44 ± 0.13 3.21 ± 1.85## 1.07 ± 0.12** 0.62 ± 0.20** 1.24 ± 0.48*
Week 10 0.46 ± 0.13 3.79 ± 2.20## 1.76 ± 0.50** 1.07 ± 0.61** 1.69 ± 0.86*
Control: rabbits fed on normal diets; Model: rabbits fed on high-cholesterol diets; Fenofibrate: rabbits received high-cholesterol diets plus fenofibrate (12 mg/kg);
Kaempferol-H: rabbits received high-cholesterol diets plus kaempferol (150 mg/kg); Kaempferol-L: rabbits received high-cholesterol diets plus kaempferol (30 mg/kg).
TC: total cholesterol; TG: triglyceride; HDL-C: high density lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol. *P<0.05, **p < 0.01, compared with model
group; ## p < 0.01, compared with control group.
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on the inflammation of vascular, we detected the serum
levels of these two inflammatory factors in the present
study. As listed in Table 3, serum TNF-α and IL-1β levels
in rabbits of model group, which received high-cholesterol
diet for ten weeks, increased notably as compared with
the control group (P<0.01). However, in contrast to the
model group, the concentrations of TNF-α and IL-1β in
the group receiving high cholesterol diet plus fenofibrate
(12 mg/kg) or kaempferol (30 mg/kg and 150 mg/kg) de-
creased significantly (P<0.05), indicating that kaempferol
has an effect on TNF-α and IL-1β releasing.Table 3 Changes of inflammatory factors in serum
(mean± SD, n=6)
Group TNF-α (pg/mL) IL-1β (pg/mL)
Control 59.18 ± 11.23 14.46 ± 1.91
Model 143.93 ± 45.64## 27.66 ± 8.11#
Fenofibrate 92.82 ± 24.21* 17.16 ± 7.38*
Kaempferol-H 80.84 ± 29.69* 19.29 ± 3.12*
Kaempferol-L 83.76 ± 21.34* 20.02 ± 5.25*
Control: rabbits fed on normal diets; Model: rabbits fed on high-cholesterol
diets; Fenofibrate: rabbits received high-cholesterol diets plus fenofibrate (12
mg/kg); Kaempferol-H: rabbits received high-cholesterol diets plus kaempferol
(150 mg/kg); Kaempferol-L: rabbits received high-cholesterol diets plus
kaempferol (30 mg/kg). TNF-α: Tumour-necrosis factor-α, IL-1β: interleukin-1β.
*P<0.05, compared with model group; # p < 0.05, ## p < 0.01, compared with
control group.Serum antioxidation analysis
To evaluate the antioxidant effect of kaempferol on vas-
cular in our experiment, we detected the serum levels of
SOD and MDA, which are two commonly used stan-
dards to access antioxidant ability. The results were
listed in Table 4. We can drawn from the table that,
comparing to the control group, serum SOD levels of
rabbits in model group dropped greatly (P<0.01), while
serum MDA levels increased remarkably after high chol-
esterol diet for six and ten weeks. After ten weeks, levels
of SOD increased and levels of MDA reduced signifi-
cantly in the group treated with fenofibrate andTable 4 Changes of serum SOD and MDA after six and
ten weeks in different groups (mean± SD, n=6)
SOD (μmol/L) MDA (μmol/L)
Group Week 6 Week 10 Week 6 Week 10
Control 119.00±15.01 106.76±33.56 1.86 ±0.69 2.26±0.70
Model 75.31±18.76## 32.64±11.31## 6.96 ±2.02## 9.29±3.15##
Fenofibrate 106.59±23.84* 85.68±23.32** 2.65±0.89** 5.89±0.92*
Kaempferol-H 101.32±24.60* 76.39±23.17** 5.10±1.38* 6.19±1.07*
Kaempferol-L 96.73±23.99 59.84±32.56* 5.49±1.77 6.43±1.22*
Control: rabbits fed on normal diets; Model: rabbits fed on high-cholesterol
diets; Fenofibrate: rabbits received high-cholesterol diets plus fenofibrate (12
mg/kg); Kaempferol-H: rabbits received high-cholesterol diets plus kaempferol
(150 mg/kg); Kaempferol-L: rabbits received high-cholesterol diets plus
kaempferol (30 mg/kg). MDA: malondialdehyde; SOD: superoxide dismutase.
*P<0.05, **p<0.01, compared with model group; ##p < 0.01, compared with
control group.
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However at the sixth week, in rabbits treated with low
dosage of kaempferol (30 mg/kg), the SOD and MDA
levels were not significantly different from the model
group (P>0.05). Six weeks may be too short for the drug
kaempferol to exhibit a notable impact on the SOD and
MDA levels.
Morphologic and histologic studies
After oil red O staining of the third aorta (between the
third and seventh intercostals artery), atherosclerosis le-
sions on the aorta were stained red. Examples of obtained
aorta stained by red oil in each groups are shown in
Figure 2a. Grossly, aortas of rabbits of the high-
cholesterol-fed model group induced deposition of
lipids and thickening of the intima. Small plaques, 0.5
to 5 mm diameter, and wide areas of fatty streak le-
sions can be seen in the aortas of model group, while
the appearance of aortic internal surface in control
group was normal and no plaques or fatty streak hadFigure 2 Effect of kaempferol on plaque and fatty steak formation in
stained aorta of the third portion; (b) Percentage of the plaques area on th
percentage of the oil red-O positive area/total internal surface area. A. Con
bar represents mean+SD (n=6). **P <0.01 compared with control group.been observed. The fenofibrate-supplemented and
kaempferol-supplemented groups developed only small
and thinner plaques at the obtained aorta portion. Per-
centage of the plaques area was expressed as the per-
centage of the aorta stained positively for oil red O on
third portion and was calculated with computer soft-
ware. Comparing to the control group, the percentage
of the plaques area changed largely in the aorta of
model rabbits (p<0.01). However, it significantly decreased
in fenofibrate group (17.79±4.69%), kaempferol-H group
(16.01±4.58%) and kaempferol-L group (20.52±8.93%) as
compared with the model group (39.79±10.20%) (P<0.01,
Figure 2b).
Representative images of the first portion of aorta (one
centimeter segment between the first and the second in-
tercostals artery) stained by H&E under light microscope
were shown in Figure 3. As we can see, the aortic seg-
ment from control group was normal and integrity, the
intima was composed of a thin endothelial cell layer and
elastic fibers layer and smooth muscle cells (SMCs).the aorta of rabbits. (a) Representative photographs of oil red O
e third portion aorta of rabbits in each group. Expressed as
trol; B. Model; C. Fenofibrate; D. Keampferol-H; E. Keampferol-L. Each
Figure 3 Cross-section of the first portion of aorta stained with hematoxylin and eosin (H&E) under light microscope (magnification×100).
a. Control; b. Model; c. Fenofibrate; d. Keampferol-H; e. Keampferol-L.
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diet exhibited obvious signs of AS, foam cells and chol-
esterol deposits were largely found in the intima. The lu-
minal endothelium was damaged and the medial smooth
muscle cells underwent proliferation. Samples of those
in groups treated with fenofibrate (12 mg/kg) and
keampferol (30 mg/kg, 150 mg/kg), showed less accu-
mulation of lipids and less damage of intima. Thinner
intima was observed compared to model group, though
there were still a few macrophages and scattered foam
cells, especially in group treated with kaempferol.
Immunohistochemical findings
E-sel, ICAM-1, VCAM-1and MCP-1 expression of the
first portion of the aorta obtained at the end of tenth week
(one centimeter segment between the first and the second
intercostals artery) was analyzed immunohistochemically.
Respective images of immunstains obtained from each
animal in every study group were shown in Figure 4a, and
the immunohistochemical score (IHS) of E-sel, ICAM-1,
VCAM-1 and MCP-1 expression were pictured in
Figure 4b. As we can see, sections of control group
did not show any staining (Figure 4a A, F, K and P).
On the contrary, E-sel, ICAM-1, VCAM-1 and MCP-
1 were strongly expressed in model rabbits fed with
high-cholesterol diet (Figure 4a B, G, L and Q).
Fenofibrate group, Kaempferol-H and Kaempferol-L
group all showed weak expression of E-sel, ICAM-1,
VCAM-1 and MCP-1(Figure 4a C-E, H-J, M-O and
R-T). According to Figure 4b, the scores of E-sel, ICAM-1,
VCAM-1 and MCP-1 expression in normal rabbits were
much low (1.50±0.55 for E-sel, 1.17±0.41 for ICAM-1,
1.00±0.63 for VCAM-1, 1.17±0.41 for MCP-1), how-
ever, they raised up greatly to a high level (11.50±1.22,
11.00±1.55, 9.50±1.22 and 9.50±1.22 respectively) in
model group with the inducing of high-cholesterol
diet. In positive control rabbits (supplemented with
fenofibrate), the expressions of E-sel, ICAM-1 and
VCAM-1 and MCP-1 were markedly reduced compared
with model group (P<0.01). 10 weeks of high-cholesterol
diet supplemented with kaempferol (30 mg/kg and
150 mg/kg) significantly lowed scores of E-sel, ICAM-1,VCAM-1 and MCP-1 expression on cells in the aorta
compared to model rabbits (P<0.01). However, down-
regulation of VCAM-1 and MCP-1 expression on cells of
the aorta of rabbits with kaempferol supplemented diet,
did not reach a statistical significance between the high
dosage group and the low dosage group (P > 0.05).
Gene expression of E-sel, ICAM-1, VCAM-1 and MCP-1
mRNA expression of E-sel, VCAM-1, ICAM-1 and
MCP-1 at the second portion aorta (one centimeter
segment between the second and the third intercostals
artery) were studied in each individual arteries by a
semi-quantitative PCR as described in Materials and
methods. Results were expressed as ratios between E-sel,
ICAM-1,VCAM-1 or MCP-1 and β-actin. Representative
gel images of PCR obtained from each animal in every
study group were shown in Figure 5. As presented in
Figure 5, samples in control animals showed normal
mRNA expression of E-sel, VCAM-1, ICAM-1 and
MCP-1, while significantly increased expression of these
genes in model animals was noticed (P<0.05). In addition,
the mRNA expression of E-sel, ICAM-1, VCAM-1 and
MCP-1 were significantly lower in the fenofibrate and
kaempferol treated animals than in the model group
(P <0.01), especially in high dosage kaempferol treated
group. However, the differences between kaempferol-H
and kaempferol-L groups were not significant (P>0.05).
Discussion
According to several epidemiological and experimental
studies, natural or synthetic products having an anti-
inflammatory action have been proven to have a strong
preventive effect on the development of atherosclerosis
[19,20]. To investigate the potential anti-inflammatory
activity of kaempferol as a new anti-atherogenic agent,
the present study was designed to evaluate the role of
kaempferol on the inflammatory progression of early
atherosclerosis in rabbits. After ten weeks of kaempferol
treatment together with high-cholesterol diet, blood lipids
and arterial lesions of rabbits were significantly deduced
compared to the untreated group. Levels of serum IL-1β
and TNF-a dropped, mRNA and protein expression of
Figure 4 Results of immunohistochemical study. a. Representative examples of immunohistochemical staining of E-sel (A-E), ICAM-1 (F-J), VCAM-1
(K-O) and MCP-1 (P-T) in the first portion of rabbit aortas (amplification ×400). b. Immunohistochemical score (IHS) of rabbit aorta sections. Control: rabbits
fed on normal diets; Model: rabbits fed on high-cholesterol diets; Fenofibrate: rabbits received high-cholesterol diets plus fenofibrate (12 mg/kg);
Kaempferol-H: rabbits received high-cholesterol diets plus kaempferol (150 mg/kg); Kaempferol-L: rabbits received high-cholesterol diets plus kaempferol
(30 mg/kg). Each bar represents mean± SD (n = 6). *P<0.05, **p < 0.01, compared with model group; ## p < 0.01, compared with control group.
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were respectively down-regulated by the treatment of
kaempferol, indicating that kaempferol can prevent athero-
sclerosis by alleviating vascular inflammation.Selectin belongs to one kinds of adhesion molecules.
Selectin family is divided into three categories: E-selectin,
P-selectin and L-selectin. They play an important role in
vascular inflammation, thrombus and plaques formation,
Figure 5 Results of gene expression by Semi-quantitative RT-PCR. Representative gel images of E-sel, ICAM-1, VCAM-1 and MCP- 1 mRNA
expression of the second portion of rabbit aortas. β-actin was used as an internal control and PCR products were visualized by ethidium bromide
staining. The data in the bar graph are quantified ratios of the signal for E-sel, ICAM-1, VCAM-1 and MCP-1 to that for β-actin with the control samples
set at 100%. Results are expressed as mean± SD (n = 6). ** p <0.01 compared with the model group, ## p < 0.01, compared with control group.
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cular endothelial cells. E-selectin (E-sel) is a cytokine se-
lect selectin and mainly located in the capillaries and
endothelial cell membrane of venules. Expression of E-sel
on non-activated endothelial cells is minimal, but it rise
up greatly when stimulated by inflammatory cytokines like
IL-1β, TNF-α and lipopolysaccharide, and this change isinduced at the transcriptional level [5]. ICAM-1 and
VCAM-1 are two frequently studied adhesion molecules
that are cytokine-inducible members of immunoglobulin
gene superfamily, they are highly expressed by arterial
endothelial cells at the atherosclerotic lesions [21]. It is
well established that E-sel, VCAM-1, ICAM-1 and
MCP-1are key molecules involved in the initiation of
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oratively promote the adhesion of monocytes and then the
migration to endothelium. Previous reports found that the
expression of VCAM-1 and ICAM-1are up-regulated by a
high cholesterol diet [22,23]. The high expression of E-sel,
ICAM-1 and VCAM-1 were also detected mainly in hu-
man atherosclerotic plaques [7]. Levels of soluble E-sel,
ICAM-1 and VCAM-1 in blood plasma were significantly
higher in patients with unstable angina, acute coronary
syndrome and atherosclerosis. These adhesion molecules
are becoming potent clinical biomarkers of CVD [24].
Monocyte chemoattractant protein-1 (MCP-1) is thought
to play a central role in filtration of monocyte /macro-
phage to the arterial wall and the recruitment of these
cells [25]. It has been demonstrated that MCP-1 expres-
sion occurs in the arterial wall in response to hypercholes-
terolemia in rabbits and MCP-1 is highly expressed in the
macrophage -rich area of the atherosclerotic lesions in hu-
man and animal models [26]. Increases in MCP-1 levels in
serum have also been observed in patients with acute cor-
onary syndromes and expression of vascular MCP-1 can
be used to predict atherosclerosis [27]. Also, it was re-
vealed that TNF-α, IL-1β as well as oxidized low density
lipoprotein (LDL) were able to induce local vascular cells
to produce MCP-1, which causes monocyte recruitment
and promotes the release of lipids, thereby enhancing the
progression of the atherosclerotic lesion [28,29]. Another
report found that the inhibition of MCP-1 expression by
gene targeting could reduce atherogenesis in LDL recep-
tor deficient mice [30].
According to some studies, flavonoids including
phloretin [31], apigenin [32] and quercetin [33,34] can
inhibit E-sel, ICAM-1, VCAM-1 or MCP-1 expression
in vitro and in vivo. In our study, mRNA and protein ex-
pressions of E-sel, ICAM-1, VCAM-1 and MCP-1 in
aorta of rabbits were all up-regulated by a high-
cholesterol diet and expressions of those three molecules
were all down-regulated by kaempferol (30 mg/kg and
150 mg/kg). Therefore, similar to the other flavonoids
mentioned above, kaempferol also showed a down-
regulation effect on E-sel, ICAM-1, VCAM-1 or MCP-1
expression in vivo.
On the initiation of inflammation, inflammatory stimuli
leads to increased secretion of pro-inflammatory cytokines
such as TNF-α and IL-1β, which can significantly induce
oxidation of LDL and promote aggregation of oxidized
LDL and macrophages, thereby lead to the formation of
foam cells, increase the binding of LDL on endothelial
cells and the expression of LDL receptor of endothelial
cells. Subsequently nuclear transcription factor-kappa B
(NF-κB) pathway is activated in response to pro-
inflammatory cytokines. This pathway plays an essential
role in inflammation through the regulation of genes en-
coding pro-inflammatory cytokines, adhesion molecules,chemokines and growth factors. The activation of these
genes will stimulating the migration and proliferation of
smooth muscle cells, promoting the development of ath-
erosclerotic plaques [35]. Studies demonstrated the activa-
tion of gene expression of endothelial cell adhesion
molecules including E-sel, ICAM-1 and VCAM-1 by
IL-1β or TNF-α in endothelial cells is mediated by NF-κB
pathway [36]. Increased IL-1β protein [37] as well as
TNF-α mRNA and protein expression [38] are found in
injured arterial smooth muscle cells, and the inhibition of
TNF-α treatment can accelerate endothelial recovery after
injury [39]. Besides, the disruption of TNF-α gene dimin-
ishes the development of atherosclerosis in ApoE-
deficient mice [40]. A resent study demonstrated that
an antibody targeting IL-1β can inhibit the progression
of atherosclerosis in vivo, highlighting the importance
of this key cytokine in cardiovascular disease [41].
Therefore, IL-1β and TNF-α are two important pro-
inflammatory cytokines in the initiation and develop-
ment of atherosclerosis.
Several studies on the anti-inflammation effect of
kaempferol in vitro have also shown that kaempferol can
down-regulate TNF-α and IL-1β expression [42,43]. In
our study, which centering on the in vivo anti-
inflammatory activity of kaempferol, we demonstrated
that kaempferol can inhibit inflammatory cell adhesion,
migration and block the initiating processes of inflam-
matory response. The effect may be medicated by redu-
cing the secretion and release of inflammatory mediators
such as TNF-α and IL-1β and decreasing the expression
of the E-sel, ICAM-1, VCAM-1 as well as MCP-1 in the
aorta of rabbits. And both high and low dosage of
kaempferol (150 mg/kg and 30 mg/kg) have a strong ef-
fect both on the gene and protein expression, but the ef-
fect was not dosage related, for there were no statistic
difference between the two groups. Maybe the treatment
dosages designed in our study were not in the linear effi-
cacy range of kaempferol. In addition, the serum TNF-α
and IL-1β levels were increased in atherosclerosis rab-
bits, and kaempferol groups showed lower TNF-α and
IL-1β levels, indicating that the down-regulation of E-sel,
ICAM-1, VCAM-1 and MCP-1 might be mediated by the
reducing of TNF-α and IL-1β.
Besides, our results suggested that kaempferol have
anti-oxidant effect on high cholesterol fed rabbits, for
that increased SOD and reduced MDA were observed
six and ten weeks post kaempferol administration. It has
been known that free radicals is highly related with
caediovascular disease and antioxidants including many
natural agents can protect the developing of CVD
[44,45]. According to some studies, kaempferol is a po-
tent and powerful superoxide scavenger [46]. The ability
of kaempferol to decrease superoxide levels by inhibiting
the activity of enzymes that generate reactive oxygen
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may play a crucial role in its antioxidant activity [47].
Many reports have shown that kaempferol and several
kaempferol-containing plants have antioxidant activity
not only in vitro, but also in vivo [48,49]. Several epi-
demiological studies reported that fruit and vegetables
rich in kaempferol can prevent cardiovascular diseases,
and intake of them reduces the risk of coronary heart
disease. The antioxidant effect of kaempferol observed
in our experiment may be mediated by protecting LDL
from oxidation, which is also one of the early processes
involved in atherosclerosis [50].
Conclusion
In summary, the present study suggested that six and ten
weeks of treatment of kaempferol (30 mg/kg, 150 mg/kg) ef-
fectively prevent atherosclerosis induced by high cholesterol
in New Zealand White rabbits. The anti-atherogenic effect
possibly works by improving antioxidant ability, reducing
the release of TNF-α and IL-1β and down-regulation the
gene and protein expression of pro-atherogenic molecules,
such as E-sel, ICAM-1, VCAM-1 and MCP-1.Further stud-
ies related to the anti-inflammatory actions of keampferol
may needed to provide more evidences for its anti-
atherosclerotic effect.
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